Fabrication of polysulphone/hydroxyapatite nanofiber composite implant and evaluation of their in vitro bioactivity and biocompatibility towards the post-surgical therapy of gastric cancer

Chemical Engineering Journal

Volumn 234, Issue , 2013, Pages 380-388

  Saravanabhavan, Shanmuga Sundar ^a   Dharmalingam, Sangeetha ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

5 Fluorouracil; Bioactivity; Cancer; Nano hydroxyapatite; Polysulphone

Indexed keywords

5-FLUOROURACIL; CANCER; DRUG RELEASE KINETICS; IN-VITRO BIOACTIVITY; NANO-HYDROXYAPATITE; NANOFIBER COMPOSITES; POLYSULPHONE; THERAPEUTIC APPLICATION;

ARTIFICIAL ORGANS; BIOACTIVITY; BIOCOMPATIBILITY; DISEASES; FUNCTIONAL POLYMERS; IMPLANTS (SURGICAL); NANOFIBERS; SURGERY; TISSUE ENGINEERING;

LOADING;

EID: 84884575738     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2013.08.076     Document Type: Article

References (35)

1. Gomes-da-Silva L.C., Santos A.O., Bimbo L.M., Moura V., Ramalho J.S., Pedroso de Lima M.C., Simoes S., Moreira J.N. Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment. Int. J. Pharma. 2012, 434:9.
2. Shen Z., Wei W., Tanaka H., Kohama K., Ma G., Dobashi T., Maki Y., Wang H., Bi J., Dai S. A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy. Pharmacol. Res. 2011, 64:410.
3. Tong S.W., Xiang B., Dong D.W., Qi X.R. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int. J. Pharm. 2012, 434:413.
4. Mori R., Yoshida K., Tanahashi T., Yawata K., Kato J., Okumura N., Tsutani Y., Okada M., Oue N., Yasui W. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells. Gastric Cancer 2012, 10.1007/s10120-012-0191-0.
5. Uchikado Y., Okumura H., Ishigami S., Setoyama T., Matsumoto M., Owaki T., Kita Y., Natsugoe S. Increased slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer 2011, 14:41.
6. Nallasamy V., Ramanathan S. Role of novel drug delivery systems in stomach specific anti-helicobacter pylori therapy. J. Pharm. Res. 2012, 5:1165-1168.
7. Arnold U., Ulbrich-Hofmann R. Natural and engineered ribonucleases as potential cancer therapeutics. Biotechnol. Lett. 2006, 28:1615-1622.
8. Charernsriwilaiwat N., Opanasopit P., Rojanarata T., Ngawhirunpat T. Lysozyme-loaded, electrospun chitosan-based nanofiber mats for wound healing. Int. J. Pharma. 2012, 427:379-384.
9. Chaturvedi K., Ganguly K., Nadagouda M.N., Aminabhavi T.M. Polymeric hydrogels for oral insulin delivery. J. Controlled Release 2012, 165:129-138.
10. Kawashima T., Nagai N., Kaji H., Kumasaka N., Onami H., Ishikawa Y., Osumi N., Nishizawa M., Abe T. A scalable controlled-release device for transscleral drug delivery to the retina. Biomaterials 2011, 32:1950-1956.
11. Chaturvedi K., Ganguly K., Kulkarni A.R., Kulkarni V.H., Nadagouda M.N., Rudzinski W.E., Aminabhavi T.M. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review. Expert Opin. Drug Deliv. 2011, 8:1455-1468.
12. Rudzinski W.E., Aminabhavi T.M. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharma. 2010, 399:1-11.
13. Munirah S., Soon H.K., Ruszymah B.H.I., Gilson K. Fibrin and poly (lactic-co-glycolic acid) hybrid scaffold promotes early chondrogenesis of articular chondrocytes: an in vitro study. J. Orthopaedic Surg. Res. 2008, 3:17.
14. Neves V., Gerondopoulos A., Heister E., Tîlmaciu C., Flahaut E., Soula B., Ravi S., Silva P., McFadden J., Coley H.M. Cellular localization, accumulation and trafficking of double - walled carbon nanotubes in human prostate cancer cells. Nano Res. 2012, 5:223-234.
15. Letchford K., Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 2007, 65:259-269.
16. Mora-Huertas C.E., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010, 385:113-142.
17. Sokolsky-Papkov M., Agashi K., Olaye A., Shakesheff K., Domb A.J. Polymer carriers for drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 2007, 59:187-206.
18. Lin X., Li Y., Chen Z., Zhang C., Luo X., Du X., Huang Y. Synthesis, characterization and electro spinning of new thermoplastic carboxymethyl cellulose (TCMC). Chem. Eng. J. 2013, 215-216:709-720.
19. Zeng J., Xu X., Chen X., Liang Q., Bian X., Yang L., Jing X. Biodegradable electrospun fibers for drug delivery. J. Controlled Release 2003, 92:227-231.
20. Peter M., Binulal N.S., Nair S.V., Selvamurugan N., Tamura H., Jayakumar R. Novel biodegradable chitosan-gelatin/nano-bioactive glass ceramic composite scaffolds for alveolar bone tissue engineering. Chem. Eng. J. 2010, 158:353-361.
21. Zheng F., Wang S., Wen S., Shen M., Zhu M., Shi X. Characterization and antibacterial activity of amoxicillin-loaded electrospun nano-hydroxyapatite/poly (lactic-co-glycolic acid) composite nanofibers. Biomaterials 2012, 34:1402-1412.
22. Zheng F., Wang S., Shen M., Zhu M., Shi X. Antitumor efficacy of doxorubicin-loaded electrospun nano-hydroxyapatite-poly (lactic-co-glycolic acid) composite nanofibers. Polym. Chem. 2013, 4(4):933-941.
23. Sopyan I., Singh R., Hamdi M. Synthesis of nano sized hydroxyapatite powder using sol-gel technique and its conversion to dense and porous bodies. Indian J. Chem. 2008, 47A:1626-1631.
24. Kokubo T., Takadama H. How useful is SBF in predicting in vivo bone bioactivity?. Biomaterials 2006, 27:2907-2915.
25. Kokubo T., Takahashi M., Yao T., Minoda M., Miyamoto T., Nakamura T., Yamamoto T. Apatite-polymer composites prepared by biomimetic process: involvement of adhesion of apatite to polymers by glow-discharge treatment. Bioceramics 1993, 327-332. Butterworth-Heinemann, London. P. Ducheyne, D. Christiansen (Eds.).
26. Li Z., Yubao L., Aiping Y., Xuelin P., Xuejiang W., Xiang Z. Reparation and in vitro investigation of chitosan/nano-hydroxyapatite composite used as bone substitute materials. J. Mater. Sci.: Mater. Med. 2005, 16:213-219.
27. Sahoo R., Sahoo S., Nayak P.L. Release behavior of anticancer drug paclitaxel from tamarind seed polysaccharide galactoxyloglucan. Eur. J. Sci. Res. 2010, 47:197-206.
28. Peppas N.A., Sahlin J.J. A simple equation for the description of sustained release. III coupling of diffusion and relaxation. Int. J. Pharm. 1989, 57:169-172.
29. Anitha A., Deepagan V.G., Divya-Rani V.V., Menon D., Nair S.V., Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr. Polym. 2011, 84:1158-1164.
30. Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials 2003, 24:2133-2151.
31. Verma M.S., Liu S., Chen Y.Y., Meerasa A., Gu F.X. Size-tunable nanoparticles composed of dextran-b-poly(D, llactide) for drug delivery applications. Nano Res. 2012, 5:49-61.
32. Tan H., Xue Y., Luana Q., Yao X. Evaluation of glycol chitosan-graft-carboxymethyl b-cyclodextrin as potential pH-sensitive anticancer drug carrier by surface plasmon resonance. Anal. Methods 2012, 4:2784.
33. Kim H.W., Knowles J.C., Kim H.E. Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic vancomycin release. J. Mater. Sci.: Mater. Med. 2005, 16:189-195.
34. Ritger P.L., Peppas N.A. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controlled Release 1987, 5:23-36.
35. Ritger P.L., Peppas N.A. A simple equation for description of solute release II Fickian and anomalous from swellable devices. J. Controlled Release 1987, 5:37-42.